These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Smyth HD Adv Drug Deliv Rev; 2003 Jul; 55(7):807-28. PubMed ID: 12842602 [TBL] [Abstract][Full Text] [Related]
63. A review of the development of Respimat Soft Mist Inhaler. Dalby R; Spallek M; Voshaar T Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496 [TBL] [Abstract][Full Text] [Related]
64. Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen. Buttini F; Glieca S; Sonvico F; Lewis DA Expert Opin Drug Deliv; 2023; 20(8):1131-1143. PubMed ID: 37767756 [TBL] [Abstract][Full Text] [Related]
65. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD. Molimard M; Till D; Stenglein S; Singh D; Krummen M Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055 [TBL] [Abstract][Full Text] [Related]